Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-06-10
著者
-
佐治 重衡
鷲見病院外科
-
NAKACHI Kei
Department of Radiobiology/Molecular Epidemiology, Radiation Effects Research Foundation
-
Nakachi K
Saitama Cancer Center Res. Inst.
-
Nakachi Kei
佐賀大学 医学部内科学
-
Nakachi Kei
放射線影響研究所 放射線生物学･分子疫学部
-
Nakachi Kei
Department Of Epidemiology Radiation Effects Research Institute
-
Hayashi S
Department Of Pathology Tokyo Metropolitan Komagome Hospital
-
Horiguchi Shinichiro
鳥取大学 医学部病態解析医学講座医用放射線学
-
SAJI Shigehira
Department of Surgery, Tokyo Metropolitan Komagome Hospital
-
OMOTO Yoko
Division of Endocrinology, Saitama Cancer Center Research Institute
-
HAYASHI Shin-ichi
Division of Endocrinology, Saitama Cancer Center Research Institute
-
EGUCHI Hidetaka
Saitama Cancer Center Research Institute
-
HAYASHI Shin-ichi
Saitama Cancer Center Research Institute
-
Saji Shigetoyo
岐阜大学 第1内科
-
Hayashi S
Department Of Pathology Osaka City University Medical School
-
Omoto Yoko
Division Of Endocrinology Saitama Cancer Center Research Institute
-
Saji Shigehira
Department Of Surgery Tokyo Metropolitan Komagome Hospital
-
Saji Shigehira
Division Of Clinical Trials And Research Department Of Breast Surgery And Oncology Tokyo Metropolita
-
Saji Shigehira
Department Of Surgery And Breast Oncology Tokyo Metropolitan Komagome Hospital
-
Okazaki Tomoki
Endocrinology University Of Tokyo Graduate School Of Medicine
-
Okazaki Tomoki
Endocrine Genetics And Hypertension Unit 4th Department Of Internal Medicine University Of Tokyo Sch
-
FUJITA Toshiro
Endocrine and Nephrology Department, University of Tokyo
-
KUROSUMI Masafumi
Department of Pathology, Saitama Cancer Center
-
KOBAYASHI Yasuhito
Department of Pathology, Saitama Cancer Center Hospital
-
YOSHIDA Nobuyuki
Division of Endocrinology, Saitama Cancer Center Research Institute
-
INOUE Akio
Division of Endocrinology, Saitama Cancer Center Research Institute
-
EGUCHI Hidetaka
Department of Radiobiology/Molecular Epidemiology, Radiation Effects Research Foundation
-
SUEMASU Kimito
Clinics of Breast Surgery, Saitama Cancer Center Hospital
-
Suemasu Kimito
Clinics Of Breast Surgery Saitama Cancer Center Hospital
-
Horiguchi Shinichiro
Department Of Pathology Tokyo Metropolitan Cancer And Infectious Disease Center Komagome Hospital
-
Hayashi Shin-ichi
Division Of Endocrinology Saitama Cancer Center Research Institute
-
Kurosumi Masafumi
Department Of Anatomy Osaka University Medical School
-
Saji Shigehira
Department Of Clinical Trials And Research Tokyo Metropolitan Komagome Hospital
-
Kobayashi Yasuhito
Department Of Pathology Saitama Cancer Center Hospital
-
Kobayashi Yasuhito
Department Of Pathology Saitama Cancer Center
-
Yoshida Nobuyuki
Division Of Endocrinology Saitama Cancer Center Research Institute
-
Fujita Toshiro
Endocrinology University Of Tokyo Graduate School Of Medicine
-
Saji Shigehira
Department Of Breast Surgery Tokyo Metropolitan Komagome Hospital
-
Inoue Akio
Division Of Endocrinology Saitama Cancer Center Research Institute
-
Kurosumi Masafumi
Department Of Pathology Saitama Cancer Center Hospital
関連論文
- ASCO2007,サンアントニオ2006トピックス--内分泌療法 (これからの乳癌診療 2008〜2009) -- (薬物療法)
- HER2を標的とした臨床試験の現状と今後の展望 乳がん (特集 分子標的マーカーに基づいた臨床試験)
- 人乳癌細胞MCF-7におけるエストラジオールのp53protein stabilityにおよぼす影響について
- 癌遺伝子産物MDM2と核内受容体Estrogen Receptorのクロストーク
- PP35 乳癌におけるMDM2遺伝子の転写亢進のメカニズム
- ドクターズ・ディベィト 集学的治療カンファレンス(第30回)乳がん 遠隔再発の予防と治療
- 当院における術後放射線治療を行った乳癌乳房温存療法例の治療成績
- 示-337 慢性膵炎合併症の治療 : 特に血管合併症に関して(示-膵臓-6(膵炎))
- HP-073-7 乳癌術前化学療法(NAC)前のセンチネルリンパ節生検(pre-treatment SNB:PSNB)症例についての検討(乳がん(センチネル2),ハイブリッドポスター,第109回日本外科学会定期学術集会)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 予後をどのように予想するか(ER,PgR,HER2などの検討) (特集 乳がん患者への適切な対応) -- (乳がんの診断--見落とさないためのノウハウ)
- エストロゲンレセプター陽性乳癌におけるMDM2の役割
- OK-432・IL-2含有W/O型エマルジョンの転移性肝癌に対する治療効果とその作用機序の検討
- p53によるエストロゲンレセプターの活性阻害とMDM2の関与
- DP-177-3 乳腺扁平上皮癌自験例10例の臨床病理学的特徴と予後(第107回日本外科学会定期学術集会)
- HER2陽性転移再発乳がんの薬物療法 (焦点 最新! 乳がんの化学療法・ホルモン療法とケア)
- ホルモン感受性,非感受性 ホルモン療法の効果予測 (乳癌--基礎と臨床の架け橋)
- Stability of Frozen Serum Levels of Insulin-like Growth Factor-I, Insulin-like Growth Factor-II, Insulin-like Growth Factor Binding Protein-3, Transforming Growth Factorβ, Soluble Fas, and Superoxide Dismutase Activity for the JACC Study
- LH-RHアゴニストおよび抗エストロゲン療法について : Luteinizing Hormone-Releasing Hormone agonist (LH-RHa) and anti Estrogen Therapy
- 閉経前乳癌の治療 (特集 分子標的のプロトタイプとしてのホルモン療法)
- SF-032-3 乳癌術前化学療法における病理学的評価方法標準化の必要性
- SF-032-2 乳癌細胞株MCF-7に対するRofecoxibの増殖抑制効果
- 乳癌における術後補助内分泌療法 (特集 ホルモン療法の最近の進歩)
- 局所・全身治療法適応決定のための,initial sentinel lymph node biopsyの重要性
- Estrogen Receptor beta cx. As a novel predictive factor of endocrine therapy in ERalpha-positive breast cancer
- A novel Decision-Tree and paradigms for primary breast cancer
- 乳癌治療における「標準」について (21世紀の外科的癌治療指針(1)乳癌治療)
- 8. 乳房切除術の適応(乳癌手術の現況とその根拠)
- ヒト化抗Her2モノクローナル抗体Herceptin治療の有用性と問題点
- 乳癌再発防止にどこまで有用か 進化したホルモン療法 (乳癌のホルモン療法 21世紀の展開)
- 血管新生からみた乳癌の悪性度 : 血管新生は何を反映するのか
- ヒト腫瘍におけるホルモン受容体の発現様式 (あゆみ 乳癌のホルモン療法--最新動向)
- Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature
- Early breast cancer
- Current Status of Antibody Therapy for Breast Cancer
- Clinical Impact of Assay of Estrogen Receptor βcx in Breast Cancer
- Estradiol Stabilizes p53 Protein in Breast Cancer Cell Line, MCF-7
- 投与にまつわるベーシック講座 (特集 7daysでかならずステップアップ! 消化器がん化学療法まるわかり塾)
- 抗悪性腫瘍薬 エベロリムス(アフィニトール)
- Large Solitary Fibrous Tumor of the Retroperitoneum : Report of a Case
- Evaluation of Carcinoembryonic Antigen mRNA in Living, Necrotic, and Apoptotic Gastric Cancer Cells by Reverse Transcriptase-Polymerase Chain Reaction
- Significance of Apoptosis Induced by Tumor Necrosis Factor-α and/or Interferon-γ Against Human Gastric Cancer Cell Lines and the Role of the p53 Gene
- Prediction of 5-Fluorouracil and Cisplatin Synergism for Advanced Gastrointestinal Cancers Using a Collagen Gel Droplet Embedded Culture
- 胃癌細胞株におけるp53発現と抗癌剤(5FU+CDDP)及びサイトカイン(TNFα+IFNγ)によるアポトーシス誘導の特徴-マイクロアレイでの検討-
- Clinical Significance of Observation of Micrometastasis in Regional Lymph Nodes Using Reverse Transcriptase-Polymerase Chain Reaction for Carcinoembryonic Antigen and Cytokeratin 20 against Cumulative Disease-Free Survival in Colorectal Cancer
- Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers
- Evaluation of Treatment for Synchronous Hepatic Metastases from Gastric Cancer with Special Reference to Long-Term Survivors
- Antitumor Effects Induced by the Combination of TNP-470 as an Angiogenesis Inhibitor and Lentinan as a Biological Response Modifier in a Rabbit Spontaneous Liver Metastasis Model
- Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation
- A Simple Method for Classification of Cell Death by Use of Thin Layer Collagen Gel for the Detection of Apoptosis and/or Necrosis after Cancer Chemotherapy
- A Ruptured Pancreaticoduodenal Artery Aneurysm Associated with a Splenic Artery Aneurysm : Report of a Case
- Therapeutic Effect of TNP-470 on Spontaneous Liver Metastasis of Colon Tumors in the Rabbit
- Centrosomal Kinases, HsAIRK1 and HsAIRK3, are Overexpressed in Primary Colorectal Cancers
- Rapid Growth of a Retroperitoneal Rhabdomyosarcoma Following Right Hemicolectomy for Ascending Colon Cancer : Report of a Case
- Recurrence of Giant Adrenocortical Carcinoma in the Contralateral Adrenal Gland 6 Years After Surgery : Report of a Case
- An Abdominal Desmoid Tumor Involving the Xyphoid and Costal Chondrium Associated with Pregnancy: Report of a Case
- Impact of Splenectomy and Immunochemotherapy on Survival Following Gastrectomy for Carcinoma: Covariate Interaction with Immunosuppressive Acidic Protein, A Serum Marker for the Host Immune System
- Weekly Schedule of Docetaxel in Breast Cancer: Evaluation of Response and Toxicity
- Aromatase and Aromatase Inhibitors
- Overexpression of MDM2 in MCF-7 Promotes Both Growth Advantage and p53 Accumulation in Response to Estradiol
- Natural Killer Activity and Its Changes among Participants in a Smoking Cessation Intervention Program : a Prospective Pilot Study of 6 Months' Duration
- JMS Report 米国のM・D・アンダーソンがんセンターによる チームオンコロジーメディアセミナー
- MRIが診断に有効であった外傷性右横隔膜ヘルニアの1例
- 817 食道癌術後5年目に左鎖骨下動脈に穿通した再建胃管潰瘍の救命例
- 食道癌術後5年目に左鎖骨下動脈に穿通した再建胃管潰瘍の1例
- Adiabatic Potentials for cis-trans Isomerization of Protonated Retinal Schiff-Base with Counter Change
- Japan-US Cooperative Cancer Research Seminar on molecular epidemiological characteristics of lung and colon cancer development among atomic-bomb survivors, Bethesda, USA, February 23-24, 2006
- EPIDEMIOLOGY OF GENETIC SUSCEPTIBILITY AND CIGARETTE SMOKING IN LUNG CARCINOGENESIS BY CYP1A1 POLYMORPHISMS
- What's going on 乳癌 A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. Cancer Cell. 2004;5:607-16. PMID:15193263--術後補助療法におけるタモキシフェンへの反応性
- 乳がん (第46回日本癌治療学会総会Educational Book) -- (教育セッション がん治療update)
- Radiation sensitivity and genomic instability in the hematopoietic system : Frequencies of micronucleated reticulocytes in whole-body X-irradiated BALB/c and C57BL/6 mice
- Perspectives on cancer immuno-epidemiology
- Changes in the Expression of Lipid-Mediated Signal-Transducing Enzymes in the Rat Liver After Partial Hepatectomy
- Usefulness of MR imaging in the postsurgical monitoring of gallbladder cancer in a patient with bile duct cancer that developed 7 years after resection of mucinous adenocarcinoma of the gallbladder
- Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1
- Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes
- Molecular Significance of Excess Body Weight in Postmenopausal Breast Cancer Patients, in Relation to Expression of Insulin-like Growth Factor I Receptor and Insulin-like Growth Factor 11 Genes
- An Rsa I Polymorphism in the CYP2E1 Gene Does Not Affect Lung Cancer Risk in a Japanese Population
- On the Models for Phytochrome Chromophore
- Risk Factors for Lung Cancer among Northern Thai Women: Epidemiological, Nutritional, Serological, and Bacteriological Surveys of Residents in High- and Low-incidence Areas
- Influenece of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients
- P-22 Studies on Houses and Kitchen in Two Suburban Areas of Chiang Mai, Northern Thailand (Proceedings of the 38th Meeting of Japan Society of Physiological Anthropology)
- II-1 Studies on Dietary Habits of Elderly Female Residents in Two Suburban Areas of Chiang Mai, Northern Thailand (Proceedings of the 38th Meeting of Japan Society of Physiological Anthropology)
- Comparison of Diets among Elderly Female Residents in Two Suburban Districts in Chiang Mai Province, Thailand, in Dry Season : Survey on High -and Low-Risk Districts of Lung Cancer Incidence
- Some Evidences of Molecular Epidemiology in Cancer Research
- On the Deformed Excited State of Retinal
- Theory of Formamide and Its Related Compounds by INDO-CI Method
- Theory of the Deformed Excited State of Polyene
- Role of MDM2 Overexpression in Doxorubicin Resistance of Breast Carcinoma
- MDM2 in Breast Cancer
- 国際共同臨床試験
- Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor
- Natural Killer Activity and Its Changes among Participants in a Smoking Cessation Intervention Program : a Prospective Pilot Study of 6 Months' Duration
- Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach
- Novel Sensitizing Agents : Potential Contribution of COX-2 Inhibitor for Endocrine Therapy of Breast Cancer
- PS-149-3 術前化学療法による腋窩リンパ節転移への治療効果と予後についての検討(PS-149 ポスターセッション(149)乳腺:化学療法-1,第111回日本外科学会定期学術集会)
- Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast
- Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition
- ER陽性乳がんに対する個別化治療 (特集 乳がんにおける多様性と個別化) -- (薬物療法における個別化)
- Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol